Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism
Open Access
- 26 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (9) , 693-701
Abstract
We evaluated prognostic value at 6 months of residual pulmonary vascular obstruction (RPVO) measured before discharge in patients with intermediate- or high-risk pulmonary embolism (PE). Prospective registry including 416 consecutive patients with intermediate- or high-risk PE who survived the acute phase. Patients with previous cardiopulmonary disease were excluded. Perfusion lung scans were performed within 6–8 days after the onset of treatment. Residual pulmonary vascular obstruction was graded as the proportion of the lung not perfused. Primary objective was a combined endpoint at 6 months, including death, recurrent PE, and appearance of signs of heart failure. At 6 months, 32 patients (7.7%) had at least one adverse event: 12 deaths (2.9%), 12 recurrent PE (2.9%), and 14 (3.4%) heart failure. Independent predictors of combined endpoint were: cancer [odds ratio (OR) 3.07 (1.22–7.85)]; renal insufficiency at admission [OR: 2.53 (1.17–5.8)]; persistent signs of right ventricular dysfunction at 48 h echography [OR: 3.99 (1.36–11.3)]. The severity of RPVO at discharge was significantly associated with an unfavourable outcome [OR: 2.66 (1.58–3.93)]. The incremental prognostic value of RPVO information was confirmed by significantly improved goodness-of-fit. Threshold RPVO for predicting adverse events was estimated at 35% [area under the curve = 0.76 (0.73–0.82)]. Patients with RPVO greater than threshold at discharge had a significantly higher risk of death at 6 months (P = 0.01). Residual pulmonary vascular obstruction evaluated before hospital discharge in patients with intermediate- to high-risk PE is a powerful prognostic factor for a 6-month outcome. RPVO ≥35% is associated with an increased risk of adverse events at 6 months.Keywords
This publication has 26 references indexed in Scilit:
- Predictive Value of the High-Sensitivity Troponin T Assay and the Simplified Pulmonary Embolism Severity Index in Hemodynamically Stable Patients With Acute Pulmonary EmbolismCirculation, 2011
- Patient Outcomes after Acute Pulmonary Embolism: A Pooled Survival Analysis of Different Adverse EventsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Prognostic Factors for Pulmonary Embolism: The PREP Study, A Prospective Multicenter Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Predictors of In‐Hospital and Long‐Term Clinical Outcome in Elderly Patients with Massive Pulmonary Embolism Receiving Thrombolytic TherapyJournal of the American Geriatrics Society, 2008
- Guidelines on the diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2008
- Prospective validation of the Pulmonary Embolism Severity IndexThrombosis and Haemostasis, 2008
- Validation of a clinical prognostic model to identify low‐risk patients with pulmonary embolismJournal of Internal Medicine, 2007
- Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary EmbolismNew England Journal of Medicine, 2004
- In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapyEuropean Heart Journal, 2003
- Pulmonary EmbolismCirculation, 1999